title: Antimicrobial peptides versus parasitic infections?
abstract: Reports of antimicrobial peptides generally have evaluations of their antibacterial and antifungal activities. By contrast, little is known of their activities against protozoan and metazoan parasites. In vitro antiparasitic assays suggest that antimicrobial peptides could represent a powerful tool for the development of novel drugs to fight the parasite in the vertebrate host, or to complement current therapeutic strategies.
authors.forename: Jacopo
authors.initials: J
authors.lastname: Vizioli
authors.forename: Michel
authors.initials: M
authors.lastname: Salzet
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology; D006801:Humans; D007891:Leishmania; D007896:Leishmaniasis / Q000188:drug therapy*; D008288:Malaria / Q000188:drug therapy*; D010455:Peptides; D010961:Plasmodium
chemical_list: D000900:Anti-Bacterial Agents; D000962:Antimalarials; D010455:Peptides